|
|
Article: BUSINESS WIRE DAILY SUMMARY - AUG 29-31, 2009.
- Article from:
- AsiaPulse News
- Article date:
- September 1, 2009
CopyrightCOPYRIGHT 2009 Asia Pulse Pty Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
A summary of news releases for August 29, 30, and 31, 2009 compiled by Business Wire, the global leader in news distribution. To view any of these news releases on Business Wire's website, please go to www.businesswire.com.
1) Category Code: Pharmaceutical
GROUNDBREAKING RESULTS IN THE RE-LY TRIAL - NOVEL ORAL DIRECT THROMBIN INHIBITOR DABIGATRAN ETEXILATE CONVINCINGLY BEATS WARFARIN - SUPERIOR STROKE REDUCTION WITH LESS BLEEDING!
Boehringer Ingelheim today announced data from the landmark RE-LY study - the largest atrial fibrillation (AF) outcomes trial ever conducted (18,113 patients in 44 countries worldwide) - presented for the first time ...